Study Group: Gastroenterologists who Treat Crohn's Disease (US)(?)

1) telaprevir appears to improve therapy in hard to treat genotype one. 2)previous treatment failures have a reason to now be retreated. 3)naive treatment patients have better chance for cure with the possibility of only 6 month rather than 12 moths of therapy

This potential issue has been of concern since we changed to Propofol based anesthesia for all of our patients approximately five years ago.  We made this decision because it made endoscopic procedures significantly more tolerable (essentially painless, except for the bowel prep) for just...

Patients with isolated proctitis remain a difficult to treat subpopulation of patients with UC.  Topical mesalamine is often efficacious, but is not always the preferred mode of administration for many patients.  As we have a variety of options as to which oral mesalamine preparation to use...

Which PPI to prescribe?  We already have a myriad of choices between brands, which in general, are all quite effective when used for the correct indications.  An oral suspension is useful in a patient who requires PPI therapy, but who is unable to swallow pills for a variety of reasons. ...

The clinical outcome information in this report regarding decreasing colectomy rate is not particularly surprising, but the cost statements may be misleading.  One wonders if the increased health care costs in the colectomy group reflect that fact that the observation period was only...